Overview

  • Product nameAnti-MAVS antibody
    See all MAVS primary antibodies
  • Description
    Rabbit polyclonal to MAVS
  • Tested applicationsSuitable for: IPmore details
    Unsuitable for: WB
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Chimpanzee, Rhesus monkey, Gorilla
  • Immunogen

    Synthetic peptide corresponding to a region between residues 250 and 300 of human MAVS (AAH44952.1).

  • Positive control
    • HeLa whole cell lysate.

Properties

Associated products

Applications

Our Abpromise guarantee covers the use of ab70825 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IP
  • Application notesIP: Use at 2-5µg/mg of lysate.


    Is unsuitable for WB.


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionRequired for innate immune defense against viruses. Acts downstream of DDX58 and IFIH1/MDA5, which detect intracellular dsRNA produced during viral replication, to coordinate pathways leading to the activation of NF-kappa-B, IRF3 and IRF7, and to the subsequent induction of antiviral cytokines such as IFN-beta and RANTES (CCL5). May activate the same pathways following detection of extracellular dsRNA by TLR3. May protect cells from apoptosis.
    • Tissue specificityPresent in T-cells, monocytes, epithelial cells and hepatocytes (at protein level). Ubiquitously expressed, with highest levels in heart, skeletal muscle, liver, placenta and peripheral blood leukocytes.
    • Sequence similaritiesContains 1 CARD domain.
    • DomainBoth CARD and transmembrane domains are essential for antiviral function. The CARD domain is responsible for interaction with DDX58 and IFIH1.
    • Post-translational
      modifications
      Ubiquitinated; undergoes 'Lys-48'-linked polyubiquitination catalyzed by ITCH; ITCH-dependent polyubiquitination is mediated by the interaction with PCBP2 and leads to MAVS proteasomal degradation.
    • Cellular localizationMitochondrion outer membrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • CARD adapter inducing interferon beta antibody
      • CARD adaptor inducing IFN beta antibody
      • Cardif antibody
      • DKFZp666M015 antibody
      • FLJ27482 antibody
      • FLJ41962 antibody
      • IFN B promoter stimulator 1 antibody
      • Interferon beta promoter stimulator protein 1 antibody
      • Ips 1 antibody
      • IPS-1 antibody
      • Ips1 antibody
      • KIAA1271 antibody
      • MAVS antibody
      • MAVS_HUMAN antibody
      • Mitochondrial anti viral signaling protein antibody
      • Mitochondrial Antiviral Signaling antibody
      • Mitochondrial antiviral signaling protein antibody
      • Mitochondrial antiviral-signaling protein antibody
      • Putative NF kappa B activating protein 031N antibody
      • Putative NF-kappa-B-activating protein 031N antibody
      • Virus induced signaling adapter antibody
      • virus induced signaling adaptor antibody
      • Virus-induced-signaling adapter antibody
      • VISA antibody
      see all

    References for Anti-MAVS antibody (ab70825)

    ab70825 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab70825.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"